Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

BioTransplant's transplant technologies covered by four new patents

Oct. 11, 1996

Evidence indicates wider application of VasoCare therapy

Oct. 11, 1996

Cytel-Baxter xenotransplantation collaboration

Oct. 11, 1996

First recombinant DTaP vaccine submitted for FDA approval

Oct. 11, 1996

SangStat's ciclosporin bioequivalent to Sandoz drug

Oct. 11, 1996

Cel-Sci forms collaboration for development of herpesvirus vaccine

Oct. 11, 1996

Protein Design Labs' humanized antibody effective in reducing kidney transplant rejection

Oct. 4, 1996

First approval for a DTaP-IPV vaccine

Oct. 4, 1996

PPL Therapeutics-RPMS xenotransplantation collaboration

Oct. 4, 1996

delta-Opioid antagonists for non-CNS applications

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....